Sirona Biochem Corp (SBM) - Total Liabilities

Latest as of July 2024: CA$4.27 Million CAD ≈ $3.09 Million USD

Based on the latest financial reports, Sirona Biochem Corp (SBM) has total liabilities worth CA$4.27 Million CAD (≈ $3.09 Million USD) as of July 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SBM cash generation efficiency to assess how effectively this company generates cash.

Sirona Biochem Corp - Total Liabilities Trend (2011–2023)

This chart illustrates how Sirona Biochem Corp's total liabilities have evolved over time, based on quarterly financial data. Check SBM cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Sirona Biochem Corp Competitors by Total Liabilities

The table below lists competitors of Sirona Biochem Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Energoinstal S.A. WAR:ENI	Poland	zł46.51 Million
Delixy Holdings Limited Ordinary Shares NASDAQ:DLXY	USA	$22.30 Million
Annexin Pharmaceuticals AB ST:ANNX	Sweden	Skr5.22 Million
Max Resource Corp V:MAX	Canada	CA$2.50 Million
Biovie Inc NASDAQ:BIVI	USA	$3.24 Million
Calibre PA:ALWIN	USA	€18.95 Million
Superior Resources Ltd AU:SPQ	Australia	AU$522.24K

Liability Composition Analysis (2011–2023)

This chart breaks down Sirona Biochem Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Sirona Biochem Corp stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.34	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	5.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sirona Biochem Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sirona Biochem Corp (2011–2023)

The table below shows the annual total liabilities of Sirona Biochem Corp from 2011 to 2023.

Year	Total Liabilities	Change
2023-10-31	CA$3.54 Million ≈ $2.56 Million	+229.26%
2022-10-31	CA$1.08 Million ≈ $778.50K	-22.27%
2021-10-31	CA$1.38 Million ≈ $1.00 Million	-33.75%
2020-10-31	CA$2.09 Million ≈ $1.51 Million	+1.09%
2019-10-31	CA$2.07 Million ≈ $1.50 Million	-31.80%
2018-10-31	CA$3.03 Million ≈ $2.19 Million	-7.90%
2017-10-31	CA$3.29 Million ≈ $2.38 Million	+110.75%
2016-10-31	CA$1.56 Million ≈ $1.13 Million	-21.95%
2015-10-31	CA$2.00 Million ≈ $1.45 Million	+22.20%
2014-10-31	CA$1.64 Million ≈ $1.18 Million	+36.84%
2013-10-31	CA$1.20 Million ≈ $865.73K	+22.51%
2012-10-31	CA$976.91K ≈ $706.69K	+33.42%
2011-10-31	CA$732.20K ≈ $529.66K	--

About Sirona Biochem Corp

V:SBM Canada Biotechnology

Market Cap

$11.23 Million

CA$15.53 Million CAD

Market Cap Rank

#26583 Global

#1112 in Canada

Share Price

CA$0.06

Change (1 day)

+0.00%

52-Week Range

CA$0.06 - CA$0.06

All Time High

CA$0.66